Annex II F1

United Kingdom

Table to be transmitted quarterly

Costs related to the COVID-19 pandemic

	Year 2020				Year 2021 ^f1
The last year of the availability period or of a possible disbursement of the Pandemic Crisis Support (whichever is earlier) is also the last year of the reporting, unless the Member State has not yet used all the funds drawn.
Items and sub-items, as necessary, accompanied with the relevant explanations to allow the Commission to perform a meaningful assessment.
This can include, inter alia, spending on hospitals; cure and rehabilitative care, ambulatory cure and rehabilitative care, diagnostics, pharmaceuticals, preventive care, health administrations, and health related long-term care.
In EUR million Time series of actual data ending at quarter of the respective report to be submitted	Q1	Q2	Q3	Q4	Q1	Q2	Q3	Q4
Healthcare, cure and prevention costs directly related to the COVID-19 pandemic
[Item]
[Further items as necessary] ^f2
Part of overall public healthcare spending estimated to be directly or indirectly attributed to addressing the impact of COVID-19 on the healthcare system ^f3
[Item]
[Further items as necessary]
Other indirect costs related to healthcare, cure and prevention due to the COVID-19 crisis
[Item]
[Further items as necessary]

Annotations

F1: Inserted by Commission Delegated Regulation (EU) 2020/1069 of 19 June 2020 amending Delegated Regulation (EU) No 877/2013 supplementing Regulation (EU) No 473/2013 of the European Parliament and of the Council on common provisions for monitoring and assessing draft budgetary plans and ensuring the correction of excessive deficit of the Member States in the euro area.

f1: The last year of the availability period or of a possible disbursement of the Pandemic Crisis Support (whichever is earlier) is also the last year of the reporting, unless the Member State has not yet used all the funds drawn.
f2: Items and sub-items, as necessary, accompanied with the relevant explanations to allow the Commission to perform a meaningful assessment.
f3: This can include, inter alia, spending on hospitals; cure and rehabilitative care, ambulatory cure and rehabilitative care, diagnostics, pharmaceuticals, preventive care, health administrations, and health related long-term care.